Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 2, 1998, Pages 658-666

  Ligneau, X ^a,f   Lin, J S ^b   Vanni Mercier, G ^b   Jouvet, M ^b   Muir, J L ^c   Ganellin, C R ^d   Stark, H ^e   Elz, S ^e   Schunack, W ^e   Schwartz, J C ^a  

^a CENTRE PAUL BROCA   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f Laboratoire Bioprojet   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CIPROXIFAN; HISTAMINE; HISTAMINE H3 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CAT; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; FLUID INTAKE; HISTAMINE RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; CATS; ELECTROENCEPHALOGRAPHY; FEMALE; GUINEA PIGS; HISTAMINE ANTAGONISTS; IMIDAZOLES; IODINE RADIOISOTOPES; MALE; METHYLHISTAMINES; MICE; NEOCORTEX; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3;

EID: 0032463756     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 3-receptors. Nature 327:117-123.
2. 3) of histamine receptor. Nature 302:832-837.
3. 3 receptor antagonist. Eur J Pharmacol 250:147-152.
4. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. 3 receptor subtypes. Br J Pharmacol 107:919-923.
6. 3 receptor-mediated modulation of water consumption in the rat. Eur J Pharmacol 232:99-103.
7. 4 receptor ligands. Partial agonism and antagonism of metoclopramide analogous benzoic esters. Arch Pharm Pharm Med Chem 328:585-594.
8. 3-receptor histmine antagonists. J Med Chem 39:3806-3813.
9. 3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. Eur J Pharmacol 164:1-11.
10. 3 receptor agonist. J Pharmacol Exp Ther 263:304-310.
11. Hill SJ, Ganellin CR, Timmennan H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levy R and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
12. 2 receptors. J Med Chem 35:2231-2238.
13. 3-receptor antagonists with benzyl ether structure or related moieties: Synthesis and structure-activity relationships. Arch Pharm Pharm Med Chem 329:379-385.
14. 3 antagonist thioperamide in models of cognition and cholinergic function. Behav Pharmacol 7:513-525.
15. Kraly FS and Miller LA (1982) Histamine elicited drinking is dependent upon gastric vagal afferents and peripheral angiotensin II in the rat. Physiol Behav 28:841-846.
16. 3 receptor antagonist, thioperamide; inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450. Br J Pharmacol 107:161-164.
17. 3 receptor revealed. Br J Pharmacol 116:2315-2321.
18. 3 receptors. J Pharmacol Exp Ther 271:452-459.
19. 3-receptor ligands in the cat. Brain Res 523:325-330.
20. Lin JS, Hou Y, Sakai K and Jouvet M (1996) Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 16:1523-1537.
21. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275.
22. 3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice. Pharmacol Biochem Behav 50:321-325.
23. 3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. Life Sci 57:2137-2144.
24. 3 receptor on sleep and wakefulness. Eur J Pharmacol 205:283-287.
25. 3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology 15:31-35.
26. Muir JL, Everitt BJ and Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313-2326.
27. 3 receptor antagonist, ondansetron. Psychopharmacology 118:82-92.
28. Oishi R, Nishibori M and Saeki K (1983) Regional distribution of histamine and tele-methylhistamine in the rat, mouse and guinea pig brain. Brain Res 280:172-175.
29. 3-agonist (R)α-methylhistamine and the antagonist thioperamide on histamine metabolism in the mouse and rat brain. J Neurochem 52:1388-1392.
30. Parker RB and Waud DR (1971) Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. II. Antagonists. J Pharmacol Exp Ther 177:1-24.
31. 2 receptors. Naunyn-Schmiedeberg Arch Pharmacol 348:558-565.
32. 2A receptor specificity, stereoselectivity and modulation of ritanserin-induced depression of 5-HT contractions in rat tail artery. J Pharm Pharmacol 47:310-316.
33. Prast H, Argyriou A and Philippu A (1996) Histaminergic neurons facilitate social memory in rats. Brain Res 734:316-318.
34. 3 heteroreceptors. Fund Clin Pharmacol 8:128-137.
35. 3H-histamine in the rat brain after intracistemal administration. Eur J Pharmacol 16:326-335.
36. Schwartz JC, Arrang JM, Garbarg M, Pollard H and Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71:1-51.
37. Schwartz JC, Arrang JM, Garbarg M and Traiffort E (1995) Histamine, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 397-405, Raven Press, New York.
38. 3 (ant)agonists. Int Pat Appl W0 96/29315 (September 26, 1996).
39. 3 receptor antagonists with high in vitro and in vivo activity. J Med Chem 39:1157-1163.
40. 3-receptor antagonists. Drugs Future 21:507-520.
41. Van Rossum JM (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143:299-329.
42. Verdière M, Rose C and Schwartz JC (1977) Turnover of cerebral histamine in a stressful situation. Brain Res 129:107-119.